Pharma News – October 4, 2019

Your weekly dose of interesting tidbits from around the pharma web…

 

Medical technology companies are reaping record sales and profits, but research and development isn’t focused on a future platform “directly linked to value creation,”  –  Forbes

 

“Drug prices are a rare area where Republicans and Democrats agree, at least in theory, that action is needed to drive them down.”  –  Biopharmadive

 

As U.S. officials press a massive case for alleged generic drug price fixing, authorities in the U.K. have unearthed an example of rivals working a little too closely with each other. King Pharmaceuticals and Alissa Healthcare Research, which both sold the antidepressant drug nortriptyline, admitted to exchanging “commercially sensitive information” in order to keep prices high  –  Fierce Pharma

 

Smartphone app provides skin cancer early warning service . –  Pharmaphorum

 

Read our latest blog “Agency Technology – Build or Buy” to learn how a technology partner can grow your agency business.

 

–  To find out more about Pharmagin, Contact Us  –

en_USEnglish
en_USEnglish